Antibodies to HBIMF63 polypeptide
    101.
    发明授权
    Antibodies to HBIMF63 polypeptide 失效
    HBIMF63多肽的抗体

    公开(公告)号:US07381800B2

    公开(公告)日:2008-06-03

    申请号:US10874484

    申请日:2004-06-24

    IPC分类号: C12N5/10 C12N5/12 C12P21/08

    CPC分类号: C07K14/47

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。

    Methods of treatment using antibodies to Neutrokine-alpha
    104.
    发明申请
    Methods of treatment using antibodies to Neutrokine-alpha 审中-公开
    使用Neutrokine-α抗体治疗方法

    公开(公告)号:US20060198784A1

    公开(公告)日:2006-09-07

    申请号:US11377165

    申请日:2006-03-17

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Methods of Treatment Using Antibodies to Neutrokine-alpha
    105.
    发明申请
    Methods of Treatment Using Antibodies to Neutrokine-alpha 审中-公开
    使用抗坏血酸α的抗体治疗方法

    公开(公告)号:US20060193859A1

    公开(公告)日:2006-08-31

    申请号:US11382837

    申请日:2006-05-11

    IPC分类号: A61K39/395 C07K16/24

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Methods of treatment of immune system related disorders using Neutrokine-alpha
    106.
    发明授权
    Methods of treatment of immune system related disorders using Neutrokine-alpha 有权
    使用Neutrokine-α治疗免疫系统相关疾病的方法

    公开(公告)号:US06881401B1

    公开(公告)日:2005-04-19

    申请号:US09589285

    申请日:2000-06-08

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Diagnostic methods using antibodies to Neutrokine-alpha
    110.
    发明授权
    Diagnostic methods using antibodies to Neutrokine-alpha 有权
    使用Neutrokine-α抗体的诊断方法

    公开(公告)号:US06562579B1

    公开(公告)日:2003-05-13

    申请号:US09588947

    申请日:2000-06-08

    IPC分类号: G01N3353

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。